BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li S, Huang XT, Wang MY, Chen DP, Li MY, Zhu YY, Yu Y, Zheng L, Qi B, Liu JQ. FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration. Front Oncol 2021;11:653005. [PMID: 34249689 DOI: 10.3389/fonc.2021.653005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Pu J, Zhang Y, Wang A, Qin Z, Zhuo C, Li W, Xu Z, Tang Q, Wang J, Wei H. ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis. Front Oncol 2021;11:754835. [PMID: 34733789 DOI: 10.3389/fonc.2021.754835] [Reference Citation Analysis]
2 Wu Y, Zhou Y, Gao H, Wang Y, Cheng Q, Jian S, Ding Q, Gu W, Yao Y, Ma J, Wu W, Li Y, Tong X, Song X, Ma S. LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism. Oxid Med Cell Longev 2021;2021:9979707. [PMID: 35069968 DOI: 10.1155/2021/9979707] [Reference Citation Analysis]